About this trial
The purpose of this academic lead study is to explore the effect of noninvasive neuromodulation of the CM-pf via tTIS for patients with disorders of consciousness.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
traumatic and nontraumatic etiology of VS/UWS or MCS according to published diagnostic criteria.
Disqualifiers
patients in coma, with less than 1 week after acute brain insult, with fluctuating diagnosis on baseline assessment, and with a metallic cerebral implant or pacemaker, and with epilepsy.
Trial design
Single group
Treatments tested in this trial
tTIS
DeviceCM-pf tTIS
Treatment groups
Trial outcomes
Primary outcomes
CRS-R total score changes
Coma Recovery Scale-Revised scale score, with score ranging from 0 to 23, was used to evaluate the consciousness condition.
Secondary outcomes
Numbers of patients with improved consciousness
EEG changes
EEG power spectra, Connectivity and ABCD model, etc
Sponsors and contacts
Click on the lead sponsor to view all of their trials.